DE602004031954D1 - Verbindungen zur behandlung von stoffwechselstörungen - Google Patents
Verbindungen zur behandlung von stoffwechselstörungenInfo
- Publication number
- DE602004031954D1 DE602004031954D1 DE602004031954T DE602004031954T DE602004031954D1 DE 602004031954 D1 DE602004031954 D1 DE 602004031954D1 DE 602004031954 T DE602004031954 T DE 602004031954T DE 602004031954 T DE602004031954 T DE 602004031954T DE 602004031954 D1 DE602004031954 D1 DE 602004031954D1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- treatment
- metabolism disorder
- metabolism
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 208000030159 metabolic disease Diseases 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49653303P | 2003-08-20 | 2003-08-20 | |
| PCT/US2004/026561 WO2005018628A1 (en) | 2003-08-20 | 2004-08-16 | Compounds for the treatment of metabolic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004031954D1 true DE602004031954D1 (de) | 2011-05-05 |
Family
ID=34216015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004031954T Active DE602004031954D1 (de) | 2003-08-20 | 2004-08-16 | Verbindungen zur behandlung von stoffwechselstörungen |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7906675B2 (de) |
| EP (1) | EP1656127B1 (de) |
| JP (1) | JP4703563B2 (de) |
| KR (1) | KR101069276B1 (de) |
| CN (2) | CN1835743A (de) |
| AT (1) | ATE502631T1 (de) |
| AU (1) | AU2004266673B2 (de) |
| BR (1) | BRPI0413758A (de) |
| CA (1) | CA2533890A1 (de) |
| DE (1) | DE602004031954D1 (de) |
| HK (1) | HK1087040A1 (de) |
| IL (1) | IL173377A (de) |
| MX (1) | MXPA06001963A (de) |
| NO (1) | NO20060502L (de) |
| NZ (1) | NZ545268A (de) |
| RU (1) | RU2349584C2 (de) |
| UA (1) | UA88772C2 (de) |
| WO (1) | WO2005018628A1 (de) |
| ZA (1) | ZA200600577B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1601251B1 (de) * | 2003-02-13 | 2014-11-12 | Wellstat Therapeutics Corporation | Verbindungen zur behandlung von stoffwechselstörungen |
| CN101912380A (zh) * | 2003-04-15 | 2010-12-15 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
| EP1617835B1 (de) * | 2003-04-30 | 2011-09-28 | Wellstat Therapeutics Corporation | Verbindungen zur behandlung von stoffwechselstörungen |
| US8022249B2 (en) * | 2005-04-01 | 2011-09-20 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| UA95613C2 (ru) * | 2005-11-09 | 2011-08-25 | Уеллстат Терепьютикс Корпорейшн | Соединения для лечения расстройсв метаболизма |
| CA2637373A1 (en) * | 2006-01-25 | 2007-08-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| EP1976377A4 (de) * | 2006-01-25 | 2010-06-23 | Wellstat Therapeutics Corp | Verbindungen zur behandlung von stoffwechselstörungen |
| US7947735B2 (en) * | 2006-01-25 | 2011-05-24 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| EP1978948A4 (de) * | 2006-02-02 | 2010-06-16 | Wellstat Therapeutics Corp | Verbindungen zur behandlung von stoffwechselstörungen |
| WO2007095462A2 (en) * | 2006-02-13 | 2007-08-23 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| MX2008011022A (es) * | 2006-02-28 | 2008-09-10 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de trastornos metabolicos. |
| NZ571118A (en) * | 2006-03-31 | 2011-12-22 | Wellstat Therapeutics Corp | Combination treatment of metabolic disorders |
| CN101437506A (zh) * | 2006-05-18 | 2009-05-20 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
| EP2026659A4 (de) * | 2006-06-09 | 2010-06-30 | Wellstat Therapeutics Corp | Verbindungen zur behandlung von stoffwechselstörungen |
| US8481595B2 (en) * | 2008-01-15 | 2013-07-09 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| CN109096350B (zh) * | 2017-09-21 | 2020-07-28 | 暨南大学 | 辣木籽中新的硫醚类化合物及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE667498A (de) | 1964-07-28 | 1965-11-16 | ||
| WO2002100341A2 (en) | 2001-06-12 | 2002-12-19 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| EP1556085A4 (de) | 2002-11-01 | 2012-08-22 | Wellstat Therapeutics Corp | Verbindungen zur behandlung von stoffwechselst rungen |
| EP1601251B1 (de) | 2003-02-13 | 2014-11-12 | Wellstat Therapeutics Corporation | Verbindungen zur behandlung von stoffwechselstörungen |
| CN101912380A (zh) | 2003-04-15 | 2010-12-15 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
| WO2004093806A2 (en) | 2003-04-22 | 2004-11-04 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| EP1617835B1 (de) | 2003-04-30 | 2011-09-28 | Wellstat Therapeutics Corporation | Verbindungen zur behandlung von stoffwechselstörungen |
-
2004
- 2004-08-16 CA CA002533890A patent/CA2533890A1/en not_active Abandoned
- 2004-08-16 CN CNA2004800235529A patent/CN1835743A/zh active Pending
- 2004-08-16 BR BRPI0413758-2A patent/BRPI0413758A/pt not_active IP Right Cessation
- 2004-08-16 CN CN2010102937097A patent/CN101948416A/zh active Pending
- 2004-08-16 JP JP2006523964A patent/JP4703563B2/ja not_active Expired - Fee Related
- 2004-08-16 UA UAA200602860A patent/UA88772C2/ru unknown
- 2004-08-16 AU AU2004266673A patent/AU2004266673B2/en not_active Ceased
- 2004-08-16 AT AT04781277T patent/ATE502631T1/de not_active IP Right Cessation
- 2004-08-16 MX MXPA06001963A patent/MXPA06001963A/es active IP Right Grant
- 2004-08-16 RU RU2006108572/04A patent/RU2349584C2/ru not_active IP Right Cessation
- 2004-08-16 EP EP04781277A patent/EP1656127B1/de not_active Not-in-force
- 2004-08-16 NZ NZ545268A patent/NZ545268A/en unknown
- 2004-08-16 US US10/566,302 patent/US7906675B2/en active Active
- 2004-08-16 KR KR1020067003221A patent/KR101069276B1/ko not_active IP Right Cessation
- 2004-08-16 WO PCT/US2004/026561 patent/WO2005018628A1/en active Application Filing
- 2004-08-16 DE DE602004031954T patent/DE602004031954D1/de active Active
-
2006
- 2006-01-23 ZA ZA200600577A patent/ZA200600577B/en unknown
- 2006-01-26 IL IL173377A patent/IL173377A/en not_active IP Right Cessation
- 2006-01-31 NO NO20060502A patent/NO20060502L/no not_active Application Discontinuation
- 2006-06-30 HK HK06107441.4A patent/HK1087040A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| UA88772C2 (ru) | 2009-11-25 |
| CN101948416A (zh) | 2011-01-19 |
| EP1656127B1 (de) | 2011-03-23 |
| CN1835743A (zh) | 2006-09-20 |
| WO2005018628A1 (en) | 2005-03-03 |
| ZA200600577B (en) | 2007-01-31 |
| NO20060502L (no) | 2006-05-03 |
| HK1087040A1 (en) | 2006-10-06 |
| ATE502631T1 (de) | 2011-04-15 |
| EP1656127A4 (de) | 2009-04-29 |
| BRPI0413758A (pt) | 2006-10-31 |
| KR101069276B1 (ko) | 2011-10-04 |
| KR20060066730A (ko) | 2006-06-16 |
| AU2004266673A1 (en) | 2005-03-03 |
| JP2007502824A (ja) | 2007-02-15 |
| IL173377A (en) | 2012-12-31 |
| IL173377A0 (en) | 2006-06-11 |
| EP1656127A1 (de) | 2006-05-17 |
| US7906675B2 (en) | 2011-03-15 |
| JP4703563B2 (ja) | 2011-06-15 |
| NZ545268A (en) | 2009-05-31 |
| US20070282003A1 (en) | 2007-12-06 |
| RU2349584C2 (ru) | 2009-03-20 |
| MXPA06001963A (es) | 2006-05-31 |
| CA2533890A1 (en) | 2005-03-03 |
| AU2004266673B2 (en) | 2010-08-05 |
| RU2006108572A (ru) | 2006-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL173377A0 (en) | Compounds for the treatment of metabolic disorders | |
| ATE402180T1 (de) | Verbindungen zur behandlung von dyslipidemie | |
| CY1106958T1 (el) | Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα | |
| ATE368031T1 (de) | Neue gamma secretase inhibitoren | |
| NO20073783L (no) | Pyrrolidininhibitorer for IAP | |
| DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
| MY137250A (en) | Method of treatment of transplant rejection | |
| ATE525067T1 (de) | Amino-substituierte (e)-2,6-dialkoxystyryl 4- substituierte benzylsulfone zur behandlung von proliferierenden erkrankungen | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
| NO20052788L (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
| ATE444749T1 (de) | Benzothiazolium verbindungen zur verwendung in methoden zur hemmung der no produktion und von tnf alpha und zur behandlung von coronavirus infektionen | |
| SE0303541D0 (sv) | New compounds | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| DE60220385D1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| ATE429909T1 (de) | Nützliche verbindungen für die behandlung von anthrax und hemmung des letalen faktors | |
| ATE516031T1 (de) | Verbindungen gegen krebs | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
| EA200701813A1 (ru) | Новые амидозамещенные 6-фенилфенантридины | |
| DE602004023100D1 (de) | Verbindungen und verfahren zur behandlung von dyslipidemie | |
| ATE432936T1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| ATE539756T1 (de) | Prostaglandinsubstanzen für die behandlung von fettsucht | |
| ATE370733T1 (de) | Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen |